392 material Form 8-K filings that 341 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
RLI Corp. reported second quarter 2024 net earnings of $82.0 million ($1.78 per share), up from $77.7 million ($1.69 per share) a year earlier. Operating earnings rose to $79.3 million ($1.72 per share) from $53.3 million ($1.16 per share), and underwriting income reached $70.0 million on an 81.5 combined ratio, compared with 87.2 in the second quarter of 2023, which points to stronger profitability for shareholders.
Net earnings $82.0 million ($1.78 per share) vs. $77.7 million ($1.69 per share) in Q2 2023
Operating earnings $79.3 million ($1.72 per share) vs. $53.3 million ($1.16 per share) in Q2 2023
Underwriting income $70.0 million on an 81.5 combined ratio, vs. $41.2 million on an 87.2 combined ratio in Q2 2023
Gross premiums written up 11%; net investment income up 18% to $34.0 million
Medpace reported second quarter 2024 results on July 22, 2024, with revenue up 14.6% year over year and GAAP net income of $88.4 million, or $2.75 per diluted share, versus $1.93 a year earlier. The company also gave full-year 2024 guidance of $2.125 billion to $2.175 billion in revenue and $11.24 to $11.93 in diluted EPS, but net new business awards fell 4.1% in the quarter.
Q2 2024 revenue was $528.1 million, up 14.6% from $460.9 million; EBITDA rose 34.2% to $112.3 million.
Q2 2024 net new business awards were $551.0 million, down 4.1% from $574.8 million, for a net book-to-bill ratio of 1.04x.
2024 guidance: revenue of $2.125 billion to $2.175 billion, GAAP net income of $361.0 million to $383.0 million, and diluted EPS of $11.24 to $11.93.
No share repurchases were made in Q2 2024; $308.8 million remained under the authorized program as of June 30, 2024.
Park National Corporation reported second-quarter 2024 net income of $39.4 million, up 24.6% from $31.6 million a year earlier, with diluted earnings per share of $2.42 versus $1.94. For the first half of 2024, net income rose 14.2% to $74.6 million, and the board declared a quarterly dividend of $1.06 per common share.
Q2 2024 net income $39.4 million vs. $31.6 million in Q2 2023; diluted EPS $2.42 vs. $1.94
First-half 2024 net income $74.6 million, up 14.2%; diluted EPS $4.60 vs. $4.01
Net interest margin 4.39% for Q2 2024, compared with 4.07% for Q2 2023
Quarterly dividend of $1.06 per share, payable September 10, 2024, to holders of record as of August 16, 2024
W. R. Berkley reported second quarter 2024 net income to common stockholders of $371.9 million, or $0.92 per diluted share, up from $356.3 million, or $0.87, a year earlier. Operating income per diluted share rose to $1.04 from $0.76, and total revenues increased to $3.31 billion from $2.99 billion. Per-share figures are adjusted for the 3-for-2 stock split effective July 10, 2024.
Net income to common stockholders was $371.9 million, or $0.92 per diluted share, versus $356.3 million, or $0.87, in the second quarter of 2023.
Operating income per diluted share was $1.04, up from $0.76; total revenues were $3.31 billion versus $2.99 billion.
The consolidated GAAP combined ratio was 91.1%, compared with 89.6% a year earlier.
The company returned $381.3 million to shareholders in the quarter, including $223.8 million of share repurchases.
Zions Bancorporation reported second-quarter 2024 net earnings of $190 million, or $1.28 per diluted share, up from $166 million, or $1.11, a year earlier. Net interest income rose 1% to $597 million and net interest margin widened to 2.98%, while customer-related noninterest income fell 5% to $154 million. Tangible book value per common share rose to $30.67 from $25.52, and the common dividend was unchanged at $0.41 per share.
Net earnings of $190 million, up from $166 million in 2Q23; diluted EPS of $1.28 vs. $1.11
Net interest margin was 2.98%, compared with 2.92% a year earlier
Customer-related noninterest income fell 5% to $154 million; pre-provision net revenue was $278 million, down 2%
Estimated CET1 capital ratio was 10.6%, compared with 10.0%; nonperforming assets rose to $265 million
Agilysys reported fiscal 2025 first-quarter total net revenue of $63.5 million, up 13.3% from $56.1 million a year earlier, and net income of $14.1 million, or $0.50 per diluted share, versus $1.1 million, or $0.04, a year earlier. The company also issued fiscal 2025 revenue guidance of $275 million to $280 million, which shareholders can use to compare against future results.
Total net revenue rose 13.3% to $63.5 million; subscription and maintenance revenue was $38.0 million, up 32.0% year over year.
Net income was $14.1 million, or $0.50 per diluted share; the filing shows a $10.2 million tax benefit from tax events in its adjusted earnings reconciliation.
Adjusted diluted EPS was $0.30 versus $0.18 a year earlier; adjusted EBITDA was $12.1 million versus $6.3 million.
Fiscal 2025 guidance: total revenue of $275 million to $280 million and adjusted EBITDA of 16% of revenue; cash balance was $144.1 million at June 30, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.